286/286
articles
286/286
articles
|
Sort by:
April 2, 2024
Icometrix has reveiced MDR clearance for icobrain ms, icobrain dm, icobrain tbi, icobrain ep, and icobrain cva. All four products are classified as class IIa. MRIguidance has upgraded their MDR...
April 2, 2024
Quibim has launched a new product, QP-Liver. This AI application is developed for the diagnosis of diffuse liver disease on MRI. The new product has received CE and UKCA approval and is therefore...
March 29, 2024
qER-Quant software by Qure.ai was used in this retrospective study to measure hematoma volume and midline shift (MLS) and quantify their relationship with age. Subdural hematoma volume and degree of...
March 29, 2024
A Norwegian retrospective study in an organized screening environment analyzed the ability of an AI system to classify breast cancers by mammographic density. The commercial AI system Transpara,...
March 29, 2024
Lunit Insight MMG is once again highlighted in another retrospective study where the associations between the positive predictive values (PPVs) of the abnormality scores generated by an AI-CAD system...
March 29, 2024
In this study, BoneMRI by MRIguidance was used as an alternative method to investigate a major unmet need for developing a sensitive assessment of structural damage in the spine in patients with...
March 28, 2024
A German retrospective study assessed InferRead DR Chest (Infervision), an AI tool for diagnosing pathological conditions on chest X-ray. The study utilized 477 chest X-rays, with a reference...
March 28, 2024
A U.S. prospective study investigated the effectiveness of BoneMRI (MRIguidance) in generating MRI-based synthetic CT (sCT) images compared to conventional CT (cCT) for evaluating pediatric hip...
March 28, 2024
A German retrospective study evaluated CorEx by Spimed-AI, an AI tool for photon-counting coronary computed tomography angiography (PC-CCTA) stenosis detection and artificial intelligence-derived...
March 27, 2024
A Spanish prospective study evaluated ChestEye Quality (Oxipit), an AI tool for analyzing 75 different pathologies on chest X-rays, using X-rays of 278 participants (48.2% with radiologic...
March 27, 2024
In a retrospective study across two Dutch hospitals, the AI tool ChestEye Quality by Oxipit analyzed 25,104 chest X-rays from 21,039 patients, acting as a secondary reviewer by comparing its image...
March 25, 2024
Lunit has given an update on its forthcoming acquisition of Volpara Health. The High Court of New Zealand has granted preliminary approval and all essential approvals under New Zealand's Overseas...